Avascular necrosis in sickle cell disease needs more definitive treatment options
British Journal of Haematology · 2025
DOI: 10.1111/bjh.19879 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Najibah A Galadanci und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Medicine, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabam…. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Osteonecrosis. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Avascular necrosis (AVN) is a bone disease caused by a temporary or definitive loss of the blood supply to bone resulting in cellular death. In people with sickle cell disease (SCD), AVN is one of the most common causes of severe chronic pain. Currently, there are very few treatment options for AVN and the current study by Casale et al. demonstrates how the use of patient‐reported outcomes can bring us one step closer to identifying optimal treatments for this debilitating condition in SCD. Commentary on: Casale et al. Long‐term outcomes of Avascular Necrosis in Sickle Cell Disease using joint‐specific patient‐reported outcome measures: Results from a multicentre study. Br J Haematol 2025; 206:310‐319.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology and Oncology, Department of Medicine, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
ORCID-Profile: Julie Kanter
Zitieren
APA
Galadanci, N. A., & Kanter, J. (2025). Avascular necrosis in sickle cell disease needs more definitive treatment options. British Journal of Haematology. https://doi.org/10.1111/bjh.19879
Vancouver
Galadanci NA, Kanter J. Avascular necrosis in sickle cell disease needs more definitive treatment options. British Journal of Haematology. 2025. doi:10.1111/bjh.19879
BibTeX
@article{Galadanci2025,
author = {Galadanci, Najibah A and Kanter, Julie},
title = {Avascular necrosis in sickle cell disease needs more definitive treatment options},
journal = {British Journal of Haematology},
year = {2025},
doi = {10.1111/bjh.19879}
}
EUVIMED